214 related articles for article (PubMed ID: 29112686)
1. Interferon regulatory factor 1 priming of tumour-derived exosomes enhances the antitumour immune response.
Yang MQ; Du Q; Varley PR; Goswami J; Liang Z; Wang R; Li H; Stolz DB; Geller DA
Br J Cancer; 2018 Jan; 118(1):62-71. PubMed ID: 29112686
[TBL] [Abstract][Full Text] [Related]
2. Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70.
Xie Y; Bai O; Zhang H; Yuan J; Zong S; Chibbar R; Slattery K; Qureshi M; Wei Y; Deng Y; Xiang J
J Cell Mol Med; 2010 Nov; 14(11):2655-66. PubMed ID: 19627400
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
4. Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6.
Guo D; Chen Y; Wang S; Yu L; Shen Y; Zhong H; Yang Y
Immunology; 2018 May; 154(1):132-143. PubMed ID: 29197065
[TBL] [Abstract][Full Text] [Related]
5. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
6. Exosomes from CIITA-transfected CT26 cells enhance anti- tumor effects.
Fan W; Tian XD; Huang E; Zhang JJ
Asian Pac J Cancer Prev; 2013; 14(2):987-91. PubMed ID: 23621273
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus 16-encoded E7 protein inhibits IFN-γ-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes.
Zhou F; Chen J; Zhao KN
J Gen Virol; 2013 Nov; 94(Pt 11):2504-2514. PubMed ID: 23956301
[TBL] [Abstract][Full Text] [Related]
8. Thyrocyte-derived exosome-targeted dendritic cells stimulate strong CD4
Cui X; Wang S; Zhao N; Wang S; Wang Z; Huang M; Liu Y; Qin J; Shan Z; Teng W; Li Y
Mol Cell Endocrinol; 2020 Apr; 506():110756. PubMed ID: 32045626
[TBL] [Abstract][Full Text] [Related]
9. IFN-γ treatment protocol for MHC-I
Stifter K; Krieger J; Ruths L; Gout J; Mulaw M; Lechel A; Kleger A; Seufferlein T; Wagner M; Schirmbeck R
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32868392
[TBL] [Abstract][Full Text] [Related]
10. Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects.
Lee YS; Kim SH; Cho JA; Kim CW
Exp Mol Med; 2011 May; 43(5):281-90. PubMed ID: 21464590
[TBL] [Abstract][Full Text] [Related]
11. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes).
Whiteside TL
Biochem Soc Trans; 2013 Feb; 41(1):245-51. PubMed ID: 23356291
[TBL] [Abstract][Full Text] [Related]
12. Interferon regulatory factor-1 is required for interferon-gamma-induced MHC class I genes in astrocytes.
Jarosinski KW; Massa PT
J Neuroimmunol; 2002 Jan; 122(1-2):74-84. PubMed ID: 11777545
[TBL] [Abstract][Full Text] [Related]
13. Interferon-regulatory factors during development of CD4 and CD8 thymocytes.
Simon AK; Desrois M; Schmitt-Verhulst AM
Immunology; 1997 Jul; 91(3):340-5. PubMed ID: 9301521
[TBL] [Abstract][Full Text] [Related]
14. Macrophages are essential for antitumour effects against weakly immunogenic murine tumours induced by class B CpG-oligodeoxynucleotides.
Buhtoiarov IN; Sondel PM; Eickhoff JC; Rakhmilevich AL
Immunology; 2007 Mar; 120(3):412-23. PubMed ID: 17163960
[TBL] [Abstract][Full Text] [Related]
15. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
16. 17beta-estradiol downregulates interferon regulatory factor-1 in murine splenocytes.
Lengi AJ; Phillips RA; Karpuzoglu E; Ahmed SA
J Mol Endocrinol; 2006 Dec; 37(3):421-32. PubMed ID: 17170083
[TBL] [Abstract][Full Text] [Related]
17. Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders.
Riazifar M; Mohammadi MR; Pone EJ; Yeri A; Lässer C; Segaliny AI; McIntyre LL; Shelke GV; Hutchins E; Hamamoto A; Calle EN; Crescitelli R; Liao W; Pham V; Yin Y; Jayaraman J; Lakey JRT; Walsh CM; Van Keuren-Jensen K; Lotvall J; Zhao W
ACS Nano; 2019 Jun; 13(6):6670-6688. PubMed ID: 31117376
[TBL] [Abstract][Full Text] [Related]
18. The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes.
Penninger JM; Sirard C; Mittrücker HW; Chidgey A; Kozieradzki I; Nghiem M; Hakem A; Kimura T; Timms E; Boyd R; Taniguchi T; Matsuyama T; Mak TW
Immunity; 1997 Aug; 7(2):243-54. PubMed ID: 9285409
[TBL] [Abstract][Full Text] [Related]
19. Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity.
Hao S; Bai O; Li F; Yuan J; Laferte S; Xiang J
Immunology; 2007 Jan; 120(1):90-102. PubMed ID: 17073943
[TBL] [Abstract][Full Text] [Related]
20. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
